{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:24:34Z","timestamp":1777465474540,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"DOI":"10.1007\/s40520-022-02196-8","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:03:13Z","timestamp":1657818193000},"page":"2373-2380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of benzodiazepines and related drugs in patients over 75\u00a0years of age and impact on cognition"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-1346","authenticated-orcid":false,"given":"Alexis","family":"Minouflet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khelifa","family":"Hamouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massinissa","family":"Haouchine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Berteaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"S\u00e9rot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Gyselinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salif","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bal\u00e9dent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadwiga","family":"Attier-Zmudka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"2196_CR1","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bcp.12023","volume":"77","author":"SD Hood","year":"2014","unstructured":"Hood SD, Norman A, Hince DA et al (2014) Benzodiazepine dependence and its treatment with low dose flumazenil. Br J Clin Pharmacol 77:285\u2013294","journal-title":"Br J Clin Pharmacol"},{"key":"2196_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","volume":"200","author":"VR Votaw","year":"2019","unstructured":"Votaw VR, Geyer R, Rieselbach MM et al (2019) The epidemiology of benzodiazepine misuse: a systematic review. Drug Alcohol Depend 200:95\u2013114","journal-title":"Drug Alcohol Depend"},{"key":"2196_CR3","first-page":"90","volume":"22","author":"S Uzun","year":"2010","unstructured":"Uzun S, Kozumplik O, Jakovljevi\u0107 M et al (2010) Side effects of treatment with benzodiazepines. Psychiatr Danub 22:90\u201393","journal-title":"Psychiatr Danub"},{"key":"2196_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/bcp.12596","volume":"80","author":"EA Davies","year":"2015","unstructured":"Davies EA, O\u2019Mahony MS (2015) Adverse drug reactions in special populations\u2014the elderly. Br J Clin Pharmacol 80:796\u2013807","journal-title":"Br J Clin Pharmacol"},{"key":"2196_CR5","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.3390\/ijerph16234623","volume":"16","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Xia Q, Wang J et al (2019) Insomnia, benzodiazepine use, and falls among residents in long-term care facilities. Int J Environ Res Public Health 16:4623","journal-title":"Int J Environ Res Public Health"},{"key":"2196_CR6","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"S de Billioti Gage","year":"2014","unstructured":"de Billioti Gage S, Moride Y, Ducruet T et al (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ 349:5205","journal-title":"BMJ"},{"key":"2196_CR7","unstructured":"Beck F, Guignard R, Haxaire C (2014) Les consommations de m\u00e9dicaments psychotropes en France. La Sant\u00e9 en action n\u00b0 427, 47"},{"key":"2196_CR8","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Am\u00e9liorer la prescription des psychotropes chez la personne \u00e2g\u00e9e. 2007. https:\/\/www.has-sante.fr\/jcms\/c_601523\/fr\/ameliorer-la-prescription-des-psychotropes-chez-la-personne-agee. Accessed 17 May 2021."},{"key":"2196_CR9","unstructured":"Richard N, Collin C, Cavali\u00e9 P, et al. Etat des lieux de la consommation des benzodiaz\u00e9pines en France. 2013. https:\/\/www.espace-cssct.fr\/toutes-les-actualites-du-chsct\/etat-des-lieux-de-la-consommation-des-benzodiazepines-en-france. Accessed 17 May 2021."},{"key":"2196_CR10","first-page":"75","volume":"22","author":"J Collin","year":"2001","unstructured":"Collin J (2001) M\u00e9dicaments psychotropes et personnes \u00e2g\u00e9es: une socialisation de la consommation. Rev Qu\u00e9b\u00e9coise Psychol 22:75\u201398","journal-title":"Rev Qu\u00e9b\u00e9coise Psychol"},{"key":"2196_CR11","doi-asserted-by":"publisher","first-page":"104472","DOI":"10.1016\/j.archger.2021.104472","volume":"96","author":"E Idil","year":"2021","unstructured":"Idil E, Aydin AE, Ates Bulut E et al (2021) Rationally decreasing the number of drugs seems to be a useful therapeutic approach in older adults: 6\u00a0month follow-up study. Arch Gerontol Geriatr 96:104472","journal-title":"Arch Gerontol Geriatr"},{"key":"2196_CR12","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. Quelle place pour les benzodiaz\u00e9pines dans l\u2019anxi\u00e9t\u00e9\u202f? 2018. https:\/\/www.has-sante.fr\/jcms\/c_2863043\/fr\/quelle-place-pour-les-benzodiazepines-dans-l-anxiete. Accessed 17 May 2021."},{"key":"2196_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci 134:382\u2013389","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"2196_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/bmj.297.6653.897","volume":"297","author":"D Goldberg","year":"1988","unstructured":"Goldberg D, Bridges K, Duncan-Jones P et al (1988) Detecting anxiety and depression in general medical settings. BMJ 297:897\u2013899","journal-title":"BMJ"},{"key":"2196_CR15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699","journal-title":"J Am Geriatr Soc"},{"key":"2196_CR16","unstructured":"Signoret JL, Signoret JL, Allard M, et al. Evaluation des troubles de m\u00e9moire et des d\u00e9sordres cognitifs associ\u00e9s B.E.C.96.\u2014R\u00e9sultats de votre recherche\u2014Banque de donn\u00e9es en sant\u00e9 publique. 1996. http:\/\/bdsp-ehesp.inist.fr\/vibad\/index.php?action=getRecordDetail&idt=249989. Accessed 16 June 2022."},{"key":"2196_CR17","unstructured":"Meyers JE, Meyers KR (1996) Rey complex figure test and recognition trial supplemental norms for children and adults. Odessa, Flor: psychological assessment resources."},{"key":"2196_CR18","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","volume":"341","author":"LF Hutchins","year":"1999","unstructured":"Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061\u20132067","journal-title":"N Engl J Med"},{"key":"2196_CR19","unstructured":"Insee. Population par sexe et groupe d\u2019\u00e2ges. https:\/\/www.insee.fr\/fr\/statistiques\/2381474#figure1_radio1. Accessed 16 June 2021."},{"key":"2196_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3143\/geriatrics.43.27","volume":"43","author":"H Orimo","year":"2006","unstructured":"Orimo H (2006) Reviewing the definition of elderly. Nihon Ronen Igakkai Zasshi Jpn J Geriatr 43:27\u201334","journal-title":"Nihon Ronen Igakkai Zasshi Jpn J Geriatr"},{"key":"2196_CR21","first-page":"489","volume":"12","author":"S Singh","year":"2014","unstructured":"Singh S, Bajorek B (2014) Defining, \u201celderly\u201d in clinical practice guidelines for pharmacotherapy. Pharm Pract 12:489","journal-title":"Pharm Pract"},{"key":"2196_CR22","doi-asserted-by":"crossref","unstructured":"Tiller JWG. Depression and anxiety. Med J Aust. 2013;199. https:\/\/www.mja.com.au\/journal\/2013\/199\/6\/depression-and-anxiety. Accessed 16 June 2022.","DOI":"10.5694\/mja12.10628"},{"key":"2196_CR23","doi-asserted-by":"crossref","first-page":"1569456","DOI":"10.1155\/2020\/1569456","volume":"2020","author":"D Nader","year":"2020","unstructured":"Nader D, Gowing L (2020) Is long-term benzodiazepine use a risk factor for cognitive decline? Results of a systematic review. J Addict 2020:1569456","journal-title":"J Addict"},{"key":"2196_CR24","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2146\/ajhp160381","volume":"75","author":"JD Picton","year":"2018","unstructured":"Picton JD, Marino AB, Nealy KL et al (2018) Benzodiazepine use and cognitive decline in the elderly. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 75:e6\u2013e12","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"key":"2196_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cger.2021.07.004","volume":"38","author":"E Ates Bulut","year":"2022","unstructured":"Ates Bulut E, Isik AT (2022) Abuse\/misuse of prescription medications in older adults. Clin Geriatr Med 38:85\u201397","journal-title":"Clin Geriatr Med"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02196-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-022-02196-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02196-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T16:19:13Z","timestamp":1676132353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-022-02196-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s40520-022-02196-8","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"2 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared no conflicts of interest for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by an independent Regional Ethical Review Board in Amiens (CPP: 2015\/6). The French Data Protection Authority (CNIL: 150075B-31) gave its consent for the data to be entered. Study was registered in clinicaltrials.gov (NCT02578303). All procedures were performed according to the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants were informed about study objectives and procedures and provided their written informed consent to participation. The consent was signed by the patients who were able to understand the main terms of the protocol; in the case of doubt in inability, the consent was signed by a family member.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}